×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

1800 Total Publications

Mapping Alzheimer’s disease progression in 1309 MRI scans: Power estimates for different inter-scan intervals
Hua, X., Lee, S., Hibar, D. P., Yanovsky, I., Leow, A. D., Toga, A. W., … Thompson, P. M.
PMID: 20139010 ; PMCID:2846999 ; 2010; Journal Neuroimage; vol. 51; no. 1; pp. 63-75; AWTYIuKfwAl_G9zjEvZB doi:10.1016/j.neuroimage.2010.01.104
The Alzheimer’s Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
Beckett, L. a., Harvey, D. J., Gamst, A., Donohue, M., Kornak, J., Zhang, H., & Kuo, J. H.
PMID: 20451874 ; PMCID:2867839 ; 2010; Journal Alzheimer's and Dementia; vol. 6; no. 3; pp. 257-264; AWTX50iGMOwVf_qbJr2x doi:10.1016/j.jalz.2010.03.002
Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline
Chou, Y.-Y., Leporé, N., Saharan, P., Madsen, S. K., Hua, X., Jack, C. R., … Thompson, P. M.
PMID: 20620663 ; PMCID:2904619 ; 2010; Journal Neurobiology of Aging; vol. 31; no. 8; pp. 1386-400; AWTX9JHXwAl_G9zjEvXW doi:10.1016/j.neurobiolaging.2010.05.001
Comparing predictors of conversion and decline in mild cognitive impairment
Landau, S. M., Harvey, D., Madison, C. M., Reiman, E. M., Foster, N. L., Aisen, P. S., … Jagust, W. J.
PMID: 20592257 ; PMCID:2906178 ; 2010; Journal Neurology; vol. 75; no. 3; pp. 230-238; AWTX9JHXwAl_G9zjEvXs doi:10.1212/WNL.0b013e3181e8e8b8
Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer’s disease
Xu, C., Wang, Z., Fan, M., Liu, B., Song, M., Zhen, X., & Jiang, T.
PMID: 20613678 ; PMCID:2954459 ; 2010; Journal Neuroreport; vol. 21; no. 12; pp. 802-7; AWTYFhFidzjauPDbjhkm doi:10.1097/WNR.0b013e32833ccaf4
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe CC1, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL
PMID: 20472326 ; 2010; Journal Neurobiol Aging; vol. 31; no. 8; pp. 1275-83; AWTYk_61wAl_G9zjEvdc doi:10.1016/j.neurobiolaging.2010.04.007
Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
Schneider, L. S., Kennedy, R. E., & Cutter, G. R.
PMID: 21414558 ; 2010; Journal Alzheimer's and Dementia; vol. 6; no. 5; pp. 367-77; AWTYl1zNwAl_G9zjEvdw doi:10.1016/j.jalz.2010.07.004
Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: A longitudinal MRI study.
Tosun, D., Schuff, N., Truran-Sacrey, D., Shaw, L. M., Trojanowski, J. Q., Aisen, P., … Weiner, M. W.
2010; Journal Neurobiology of Aging; vol. 31; no. 8; pp. 1340-1354; AWURKSUQdzjauPDbjhpj doi:10.1016/j.neurobiolaging.2010.04.030
The Alzheimer's disease neuroimaging initiative: perspectives of the Industry Scientific Advisory Board
Schmidt ME1, Siemers E, Snyder PJ, Potter WZ, Cole P, Soares H.
PMID: 20451878 ; 2010; Journal Alzheimers Dement; vol. 6; no. 3; pp. 286-90; AWTYlga6dzjauPDbjhn_ doi:10.1016/j.jalz.2010.03.010
Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
Schneider, L. S., Kennedy, R. E., & Cutter, G. R.
PMID: 21414558 ; 2010; Journal Alzheimer's and Dementia; vol. 6; no. 5; pp. 367-77; AWTYlga6dzjauPDbjhoD doi:10.1016/j.jalz.2010.07.004